RCEL - AVITA Medical appoints Cary Vance as interim CEO
2025-10-17 02:09:37 ET
More on AVITA Medical
- AVITA Medical: Reimbursement Reset And Breakeven Path By 2026
- AVITA Medical, Inc. (RCEL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
- AVITA Medical: Green Shoots Peaking Out From Hard Clay
- Avita Medical stock jumps 10% after securing CE Mark for RECELL GO
- Avita projects $76M–$81M 2025 revenue with rebound expected as claims backlog eases